Physician profile
Brian Rinker
NPI 1902861867
$7,961.38
in general payments reported to CMS, 2019-2025
14 companies · $1,308 in 2025
The $1,308 reported for 2025 was more than what 78% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $254 · 2021: $2,787 · 2022: $1,715 · 2023: $447 · 2024: $1,329 · 2025: $1,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,083.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,815.60 | 2020-2022 | |
| Mentor Worldwide LLC | $1,443.20 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $1,086.14 | 2019-2022 | |
| Abbvie INC. | $809.68 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $425.26 | 2022 | |
| Motiva USA, LLC | $332.59 | 2024 | |
| Access Pro Medical, LLC | $326.82 | 2025 | Matriderm |
| Axogen | $237.65 | 2019-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Tepha INC | $159.30 | 2020 | |
| Checkpoint Surgical, INC | $134.81 | 2021 | |
| Depuy Synthes Sales INC. | $59.35 | 2025 | Trumatch, Matrixmidface, Matrixmandible |
| W. L. Gore & Associates, INC. | $58.88 | 2025 | Gore Bio-A Tissue Reinforcement |
| Innovation Technologies INC | $50.00 | 2021 | |
| Davol INC. | $22.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Rinker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.